News | December 22, 2023
JB Pharma buys opthalmology brands from Novartis for Rs 964 Cr
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
ABDM Microsites Mobile Application for field officers and ABDM Microsites Dashboard launched for effective on-ground implementation and monitoring
10+ emerging markets, Japan & ANZ transition in final phase
Cresemba is the only azole antifungal therapy approved for pediatric patients as young as one affected by these serious, potentially life-threatening infections
Approximately 16,000 patients 12 years of age and older with severe sickle cell disease may now be eligible for this one-time treatment
This product will be manufactured by Indoco Remedies at their manufacturing facility located at Goa
GMM Pfaudler US completes acquisition of MixPro
Norgestrel and Ethinyl Estradiol Tablets USP (RLD: Lo/Ovral-28) had estimated annual sales of US $33 million in the US
Both the India and GCC entities will be operated by separate dedicated management teams
The divestment is a part of Fortis' ongoing portfolio rationalization strategy
Subscribe To Our Newsletter & Stay Updated
